Isis Pharmaceuticals, Inc. Discovers User Access With Varonis DatAdvantage
BOSTON, MA and NEW YORK, NY--(Marketwire - September 25, 2012) - Varonis, the leader in comprehensive data governance software, today confirmed that Isis Pharmaceuticals is using its DatAdvantage to manage and monitor file access activity. Like any organization, Isis was increasingly finding it complex and frustrating to keep track of its permission infrastructure. Today, using the intelligence collected by DatAdvantage, Isis is able to easily determine who has access to any particular folder. Conversely it can also discover which folders a user or group has access to.
Isis Pharmaceuticals is the leader in anti-sense drug development with a broad pipeline of drugs that are applicable to many different disease targets including cardiovascular, metabolic, severe and rare diseases, and cancer. Its anti-sense technology provides a direct route from genes to drugs with the opportunity to dramatically improve industry drug discovery productivity.
Speaking about its requirements, Shannon McVeigh, responsible for infrastructure support, said, "Often I would need to mirror permissions for one user to another but this was easier said than done. Groups in Active Directory did not correlate to the names of the folders. In honesty I didn't have an easy way to determine exactly who had access to what. Now, with DatAdvantage, when I want to add any user to a group, I can see exactly what they will have access to on the filers when the change is made. I can also see which filer has different securities, and even what does or doesn't inherit what."
Varonis DatAdvantage aggregates Active Directory user and group details, ACL information and all data access events -- without requiring native OS auditing -- to build a complete picture of who can and who is accessing data, and who should have their access revoked. Using the intelligence collected by DatAdvantage, Isis is able to determine who has access to any particular folder. Conversely it can also be used to discover which folders a user or group has access to. Now when a service request is received that a user needs access to a folder, it can see instantly what needs to be changed with the process reduced from 20 to just five minutes.
Using DatAdvantage, Isis is able to determine which users have been added, or even removed, from any group and exactly when it was completed. Using these reports can help it to demonstrate compliance with Sarbanes-Oxley requirements.
A happy side effect Isis has realized since deploying DatAdvantage is that it can use the statistics collected to determine who is accessing what files the most, or reversely which are not being accessed at all. This will help with its clean up efforts, and subsequent archiving of stale data, in the future.
ABOUT VARONIS® SYSTEMS
Varonis (www.varonis.com) is the leader in unstructured and semi-structured data governance software. Based on patented technology and a highly accurate analytics engine, Varonis solutions give organizations total visibility and control over their data, ensuring that only the right users have access to the right data at all times from all devices, all use is monitored, and abuse is flagged.
Varonis makes digital collaboration secure, effortless and efficient so that people can create and share content easily with whom they must, and organizations can be confident their content is protected and managed efficiently.
Voted one of the "Fast 50 Reader Favorites" on FastCompany.com, and winner of the SC Magazine Innovation, Product or Service of the Year, and Best Network Security Awards, Varonis has more than 4,500 installations worldwide and is headquartered in New York, with regional offices in Europe, Asia and Latin America.
Varonis, the Varonis logo, DatAdvantage®, DataPrivilege® and the IDU Classification Framework® are registered trademarks of Varonis® Systems in the United States and/or other countries and Metadata Framework™ and DatAnywhere™ are under a registration process in the United States and/or other countries. All other product and company names and marks mentioned in this document are the property of their respective owners and are mentioned for identification purposes only.